checkAd

     149  0 Kommentare CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021 - Seite 3

    Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.

    CytomX Contact:
    Chau Cheng, PhD MBA
    VP, Investor Relations & Corp. Communications
    ccheng@cytomx.com
    Direct: (650) 273-4999

    Lesen Sie auch

    Investor and Media Contact:
    Stern Investor Relations
    Stephanie Ascher
    stephanie.ascher@sternir.com
    212-362-1200


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021 - Seite 3 SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) - CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally-active antibody …